Which of the following are a class of oral antidiabetic medications that reduce insulin resistance in target tissues, enhancing insulin action without directly stimulating insulin secretion?
A. Dipeptide peptidase-4.
B. Thiazolidinedione.
C. Alpha-glucosidase inhibitors.
D. First- and second-generation sulfonylureas.